2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine(63868-61-1)
- Name: 2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
- Synonyms:Morpholine,5-ethyl-2,3-dimethyl-4-(3,4,5-trimethoxybenzoyl)- (7CI,9CI)
- Molecular Formula:C18H27 N O5
- Molecular Weight:337.41
- CAS Registry Number:63868-61-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.63868-61-1 2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.63868-61-1 2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.63868-61-1 2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 61450-23-5/1-[10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl]-N-methyl-3-azetidinamine
- 172304-09-5/Lanosta-7,25-dien-18-oic acid,20-hydroxy-3-[(O-3-O-methyl-6-Osulfo- â-D-glucopyranosyl-(1f3)-O-6-Osulfo- â-D-glucopyranosyl-(1f4)-O-[â-Dxylopyranosyl-( 1f2)]-O-6-deoxy-â-Dglucopyranosyl-( 1f2)-4-O-sulfo-â-Dxylopyranosyl) oxy]-,ç-lactone,trisodium salt,(3â)-
- 127305-92-4/O-((-((N-(phenylmethoxycarbonyl)alanyl)amino)ethyl)hydroxyphosphinyl)-3-phenylacetate
- 97765-70-3/Cheese, Cheddar, ext.
- 93673-37-1/(9S,10S)-9,10-dihydrocyclopenta[ij]tetraphene-9,10-diol
- 86223-08-7/4-(4,10-dihydro-10-oxothieno(3,2-c)(1)-benzoxepin-8-yl)butanol
- 78308-46-0/methyl 3,4,6-tri-O-acetyl-2-{acetyl[(2-chloroethyl)(nitroso)carbamoyl]amino}-2-deoxy-alpha-D-glucopyranoside
- 12190-79-3/Lithium cobalt(iii) oxide
- 47900-24-3/Vasoactive intestinal peptide (22-28)
- 2825-08-3/1,5-Methano-6H-azocino[4,3-b]indol-6-one,12-ethyl-1,2,3,4,5,7-hexahydro-2-methyl-,(1R,5S,12S)-
- 5394-59-2/4-(2,5-DIMETHYL-PHENYL)-4-OXO-BUTYRIC ACID
- 129224-33-5/KT 89
- 32567-44-5/2-Phenazinamine,8-fluoro-3,5-dihydro-3- [(1-methylethyl)imino]-N,5-diphenyl-
- 2507-91-7/gloxazone
- 140-73-8/N,N'-Dicinnamylidene-1,6-hexanediamine
- 16747-32-3/2,2-Dimethyl-3-ethylpentane
- 54556-98-8/Propiverine hydrochloride
- 136722-73-1/(5R)-9-chloro-5-methyl-6-(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one
- 63868-61-1/2,3-Dimethyl-5-ethyl-4-(3,4,5-trimethoxybenzoyl)morpholine
- 36978-41-3/2,3,3',4'-BIPHENYL TETRACARBOXYLIC DIANHYDRIDE
- 150586-64-4/1H-Imidazole,5-(5-fluoro-2,3-dihydro-1H-inden-2-yl)-
- 126956-10-3/(2E)-N-(3-methoxyphenyl)-2-[(1-methyl-1H-pyrrol-2-yl)methylidene]hydrazinecarbothioamide
- 19780-44-0/4-ETHYL-3-HEXANOL
- 24393-53-1/ETHYL TRANS-4-BROMOCINNAMATE
- 585-21-7/DL-Glutamine
- 50332-00-8/5-(3-Chlorobenzoyl)-6-methyl-5H-1,3-dioxolo[4,5-f]indole-7-acetic acid
- 7783-81-5/Uranium hexafluoride
- 6579-03-9/1,4-Dithiin-2,3,5,6-tetracarbothioic2,3:5,6-bis(anhydrosulfide)
- 13757-43-2/(1R,8S)-bicyclo[6.1.0]nonane
- 6563-13-9/6-METHOXYQUINOLINE N-OXIDE